Kanker Payudara

The GENEROUS Model: Evaluating the Trump Administration’s Strategy to Curb Medicaid Drug Costs the-generous-model-evaluating-the-trump-administrations-strategy-to-curb-medicaid-drug-costs

The GENEROUS Model: Evaluating the Trump Administration’s Strategy to Curb Medicaid Drug Costs

Neng Nana May 9, 2026

As Medicaid spending on prescription drugs continues to climb, the federal government and state legislatures are intensifying...

Breakthroughs in the Fight Against Stage IV: New Research Cohort Targets the Frontiers of Metastatic Breast Cancer breakthroughs-in-the-fight-against-stage-iv-new-research-cohort-targets-the-frontiers-of-metastatic-breast-cancer

Breakthroughs in the Fight Against Stage IV: New Research Cohort Targets the Frontiers of Metastatic Breast Cancer

Basiran May 9, 2026

CITY OF INDUSTRY / NATIONAL CANCER RESEARCH UPDATE — In a decisive move to address the deadliest...

Empowering Progress: METAVIVOR Launches 2026 Grant Cycle Amidst a Landscape of Hope and Innovation empowering-progress-metavivor-launches-2026-grant-cycle-amidst-a-landscape-of-hope-and-innovation

Empowering Progress: METAVIVOR Launches 2026 Grant Cycle Amidst a Landscape of Hope and Innovation

Layla Zulfa May 9, 2026

By Editorial Staff As the medical community continues to push the boundaries of oncology, the quest for...

Beyond the Greige: Why Your Gym Wardrobe Needs a Color Revolution beyond-the-greige-why-your-gym-wardrobe-needs-a-color-revolution

Beyond the Greige: Why Your Gym Wardrobe Needs a Color Revolution

Asep Darmawan May 9, 2026

The Monochrome Epidemic in Modern Fitness Walking into a modern fitness center or a boutique yoga studio...

The Genetic Blueprint for a Greener Future: How Genomics is Saving Our Forests the-genetic-blueprint-for-a-greener-future-how-genomics-is-saving-our-forests

The Genetic Blueprint for a Greener Future: How Genomics is Saving Our Forests

Sagoh May 9, 2026

Introduction: Decoding the Silent Giants For centuries, humanity has viewed forests as static backdrops—passive witnesses to the...

Revolutionizing Breast Cancer Screening: Landmark WISDOM Study Advocates for Personalized Risk-Based Approach revolutionizing-breast-cancer-screening-landmark-wisdom-study-advocates-for-personalized-risk-based-approach

Revolutionizing Breast Cancer Screening: Landmark WISDOM Study Advocates for Personalized Risk-Based Approach

Asep Darmawan May 9, 2026

SAN FRANCISCO, CA – December 12, 2023 – A groundbreaking new study, known as the WISDOM study,...

Beyond the Surface: The Vital Role of Scar Management in Cancer Recovery beyond-the-surface-the-vital-role-of-scar-management-in-cancer-recovery

Beyond the Surface: The Vital Role of Scar Management in Cancer Recovery

Suro Senen May 9, 2026

By Editorial Staff, based on insights from Berfin Mahmut, PT, DPT, CLT-LANA, OnCS For many cancer survivors,...

A Paradigm Shift in Neuro-Oncology: UCLA Researchers Advance Tailored EGFR-Targeted Therapy for Glioblastoma a-paradigm-shift-in-neuro-oncology-ucla-researchers-advance-tailored-egfr-targeted-therapy-for-glioblastoma

A Paradigm Shift in Neuro-Oncology: UCLA Researchers Advance Tailored EGFR-Targeted Therapy for Glioblastoma

Laily UPN May 9, 2026

In the relentless battle against glioblastoma—the most aggressive and lethal form of primary brain cancer—a team of...

The "Placebo Problem": How High Response Rates are Stalling Cancer Treatment Breakthroughs the-placebo-problem-how-high-response-rates-are-stalling-cancer-treatment-breakthroughs

The "Placebo Problem": How High Response Rates are Stalling Cancer Treatment Breakthroughs

Neng Nana May 9, 2026

For decades, the oncology community has grappled with a persistent and frustrating reality: while researchers have made...

Advancing Urological Diagnostics: Bright Uro’s Glean System Receives Pivotal FDA Clearance advancing-urological-diagnostics-bright-uros-glean-system-receives-pivotal-fda-clearance

Advancing Urological Diagnostics: Bright Uro’s Glean System Receives Pivotal FDA Clearance

Lina Hope May 9, 2026

The landscape of urological diagnostics is undergoing a significant transformation. Bright Uro, a California-based medical technology innovator,...

The GENEROUS Model: Evaluating the Trump Administration’s Strategy to Curb Medicaid Drug Costs

Breakthroughs in the Fight Against Stage IV: New Research Cohort Targets the Frontiers of Metastatic Breast Cancer

Empowering Progress: METAVIVOR Launches 2026 Grant Cycle Amidst a Landscape of Hope and Innovation

Beyond the Greige: Why Your Gym Wardrobe Needs a Color Revolution

The Genetic Blueprint for a Greener Future: How Genomics is Saving Our Forests

Revolutionizing Breast Cancer Screening: Landmark WISDOM Study Advocates for Personalized Risk-Based Approach

Beyond the Surface: The Vital Role of Scar Management in Cancer Recovery

A Paradigm Shift in Neuro-Oncology: UCLA Researchers Advance Tailored EGFR-Targeted Therapy for Glioblastoma

The "Placebo Problem": How High Response Rates are Stalling Cancer Treatment Breakthroughs

Advancing Urological Diagnostics: Bright Uro’s Glean System Receives Pivotal FDA Clearance

You may have missed

A New Era in Medicine: CRISPR-Based Gene Therapy Casgevy Approved for NHS Patients

Roche Expands Trontinemab’s Horizon in Alzheimer’s Fight with Pre-Symptomatic Trial and Promising Phase III Data

Biotech Breakthrough: Veradermics’ Oral Minoxidil Trial Marks Potential Paradigm Shift in Hair Loss Treatment

FDA Expands Scope of Palbociclib: A New Maintenance Strategy for HR+/HER2+ Metastatic Breast Cancer